TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34246233

Group type: EXPERIMENTAL
Intervention: Mothers and Babies intervention
Number of subjects: 738

Group type: COMPARATOR
Intervention: Control group (home visiting programs)
Number of subjects: 738
Study: 32030504

Group type: EXPERIMENTAL
Intervention: ACL-deficient group
Number of subjects: 2344

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2344
Study: 35048891

Group type: EXPERIMENTAL
Intervention: Psychological treatment (seven group sessions of transdiagnostic cognitive-behavioural therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychological treatment
Number of subjects: 0
Study: 33038087

Group type: EXPERIMENTAL
Intervention: Doxorubicin-loaded polyethylene glycol microspheres (DEM-TACE)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional TACE (c-TACE)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both DEM-TACE and c-TACE
Number of subjects: 60

Group type: COMPARATOR
Intervention: c-TACE
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: DEM-TACE
Number of subjects: 60
Study: 32390736

Group type: EXPERIMENTAL
Intervention: Dynamic Stretching (DS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dynamic Stretching followed by Vibration Foam Rolling (DS + VFR)
Number of subjects: 40
Study: 35366217

Group type: EXPERIMENTAL
Intervention: Study group (children at risk of SDB)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Control group (children with negative PSQ results)
Number of subjects: 131
Study: 34222793

Group type: EXPERIMENTAL
Intervention: Shamiri-Digital (focused on gratitude, growth mindsets and values)
Number of subjects: 926

Group type: EXPERIMENTAL
Intervention: Digital-CBT (focused on behavioural activation, cognitive restructuring and problem solving)
Number of subjects: 926

Group type: COMPARATOR
Intervention: Study-skills control condition (focused on note-taking and essay writing skills)
Number of subjects: 926
Study: 34915576

Group type: EXPERIMENTAL
Intervention: sarilumab 150 mg
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: sarilumab 200 mg
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: sarilumab (150 mg or 200 mg)
Number of subjects: 334
Study: 33883301

Group type: EXPERIMENTAL
Intervention: Neuromuscular training (NM)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional training (CONV)
Number of subjects: 22
Study: 36336743

Group type: EXPERIMENTAL
Intervention: Nebulized verapamil (10 mg, 4 ampoules of 2.5 mg/ml verapamil solutions)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nebulized distilled water (placebo)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nebulized verapamil (10 mg)
Number of subjects: 30
Study: 33773221

Group type: EXPERIMENTAL
Intervention: Productive failure
Number of subjects: 344

Group type: COMPARATOR
Intervention: Direct instruction
Number of subjects: 344
Study: 33205810

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 44

Group type: COMPARATOR
Intervention: Gliclazide
Number of subjects: 44
Study: 35452752

Group type: EXPERIMENTAL
Intervention: IMRT + GDP + chidamide (chidamide group)
Number of subjects: 74

Group type: COMPARATOR
Intervention: IMRT + GDP (control group)
Number of subjects: 74
Study: 34491323

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 7213

Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 7213
Study: 34112703

Group type: EXPERIMENTAL
Intervention: Hyperinflammatory subphenotype
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Hypoinflammatory subphenotype
Number of subjects: 568
Study: 33540841

Group type: EXPERIMENTAL
Intervention: 900 mg/day of polyphenol-rich supplement
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 32508183

Group type: EXPERIMENTAL
Intervention: Usual care physiotherapy with app‐based supplemental exercise programme
Number of subjects: 144

Group type: COMPARATOR
Intervention: Usual care physiotherapy
Number of subjects: 144
Study: 36426355

Group type: EXPERIMENTAL
Intervention: Probiotics (Bifidobacterium Tetragenous viable Bacteria Tablets)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 276
Study: 33006656

Group type: EXPERIMENTAL
Intervention: Baseline FDG-PET/CT imaging with positive results and focal bone lesions (FLs) and/or extramedullary disease (EMD)
Number of subjects: 139
Study: 35985981

Group type: EXPERIMENTAL
Intervention: Androgen Deprivation Therapy with Docetaxel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Androgen Deprivation Therapy without Docetaxel
Number of subjects: 0
Study: 34085149

Group type: EXPERIMENTAL
Intervention: Early cannabis (EC, n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Delayed start cannabis (DC, n = 15)
Number of subjects: 30
Study: 32424568

Group type: EXPERIMENTAL
Intervention: Monitor group (MG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ocular group (OG)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Preclinical data
Number of subjects: 20
Study: 35113021

Group type: EXPERIMENTAL
Intervention: Reboot Online combined with telephone support (n=44)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Reboot Online alone (n=45)
Number of subjects: 89
Study: 34098033

Group type: COMPARATOR
Intervention: CCC
Number of subjects: 26810

Group type: EXPERIMENTAL
Intervention: 30:2
Number of subjects: 26810
Study: 32938444

Group type: COMPARATOR
Intervention: 300 mg CQ (Control)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 300 mg CQ and 2 gm azithromycin (CQAZ)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: CQAZ
Number of subjects: 18
Study: 33497252

Group type: EXPERIMENTAL
Intervention: Whole-pelvic radiotherapy (WPRT, 68 Gy/25# to prostate, 50 Gy/25# to pelvic nodes)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Prostate-only radiotherapy (PORT, 68 Gy/25# to prostate)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Whole-pelvic radiotherapy (WPRT)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Prostate-only radiotherapy (PORT)
Number of subjects: 224
Study: 33186054

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg once daily
Number of subjects: 4304

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4304
Study: 33378671

Group type: EXPERIMENTAL
Intervention: Endurance exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 0
Study: 35581970

Group type: EXPERIMENTAL
Intervention: Mindfulness cognitive intervention method (MBCT)
Number of subjects: 22
Study: 33759678

Group type: EXPERIMENTAL
Intervention: Supplement (SUPP) - 200-mL carton of juice-based emulsion containing 3000 mg LC n-3 PUFA (1500 mg DHA and 1500 mg EPA), 8 g whey protein isolate, 400 IU vitamin D3, 150 mg resveratrol
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Supplement (SUPP)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 37
Study: 34895285

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) for 16 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Written information only (Control group)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Cough-suppression techniques (CST)
Number of subjects: 42
Study: 35965483

Group type: EXPERIMENTAL
Intervention: Calorie restriction (CR)
Number of subjects: 220
Study: 33722490

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided femoral punctures
Number of subjects: 1388

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided radial punctures
Number of subjects: 1388

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided femoral access (trainees)
Number of subjects: 1388

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided radial access (trainees)
Number of subjects: 1388

Group type: COMPARATOR
Intervention: Standard transradial access
Number of subjects: 1388
Study: 32122216

Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg twice daily
Number of subjects: 110

Group type: COMPARATOR
Intervention: Prasugrel 10 mg once a day
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 110

Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 110
Study: 34936948

Group type: EXPERIMENTAL
Intervention: Breads made with two different wheat evolutionary populations (Bio2, ICARDA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control breads (modern variety Bologna)
Number of subjects: 12
Study: 32993653

Group type: EXPERIMENTAL
Intervention: Echium amoenum (EA) 450 mg capsules per day (three times a day) for two consecutive cycles
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 35297731

Group type: EXPERIMENTAL
Intervention: Randomised Stimulation Level (RSL)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Conventional stimulation paradigm
Number of subjects: 11
Study: 33028427

Group type: EXPERIMENTAL
Intervention: Flaxseed (20 g/d)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Puffed wheat (25 g/d)
Number of subjects: 72
Study: 35400174

Group type: EXPERIMENTAL
Intervention: Flunarizine
Number of subjects: 84
Study: 34337919

Group type: EXPERIMENTAL
Intervention: Left paratracheal pressure (LPP)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Cricoid pressure (CP)
Number of subjects: 108
Study: 32521299

Group type: EXPERIMENTAL
Intervention: Buffered hypertonic seawater (BHS)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Physiological seawater (PS)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Buffered hypertonic seawater (BHS) in nonECRSwNP subgroup
Number of subjects: 93

Group type: COMPARATOR
Intervention: Physiological seawater (PS) in nonECRSwNP subgroup
Number of subjects: 93
Study: 35840947

Group type: EXPERIMENTAL
Intervention: Information provided in the patient admission area by the same staff member (Group A)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Information provided in a separate room by another staff member (Group B)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 263
Study: 32773268

Group type: EXPERIMENTAL
Intervention: Intravenous and periarticular steroids (IVPAS)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Intravenous steroids only
Number of subjects: 46
Study: 33923244

Group type: EXPERIMENTAL
Intervention: 30 min of moderate intensity aerobic exercise (walking) (A)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 30 min of combined aerobic and resistance exercise (AR)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 30 min of combined resistance and aerobic exercise (RA)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 15 min of resistance exercise (R)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Uninterrupted sitting (CON)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Comparison of A and AR to RA
Number of subjects: 8
Study: 33121471

Group type: EXPERIMENTAL
Intervention: Aspirin plus Metformin (100 mg aspirin and 250 mg metformin for 8 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin plus Placebo (100 mg aspirin and placebo for 8 weeks)
Number of subjects: 0
Study: 34728786

Group type: EXPERIMENTAL
Intervention: Novel intraoral cooling device (ICD)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Ice cooling (IC)
Number of subjects: 172
Study: 32512071

Group type: EXPERIMENTAL
Intervention: Chronic Cd exposure in RWPE1 and PWR1E cells
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Two-week Cd exposure in DU 145 cells
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Cd exposure in RWPE1 and PWR1E cells
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Erk/MAPK pathway activation
Number of subjects: 3
Study: 36372695

Group type: EXPERIMENTAL
Intervention: Probiotic (Lactobacillus ruteri, 100 mg)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 450
Study: 34601835

Group type: EXPERIMENTAL
Intervention: Cook balloon uterine stent placed for 37 days in Group A
Number of subjects: 98

Group type: COMPARATOR
Intervention: Cook balloon uterine stent placed for 7 days in Group B
Number of subjects: 98
Study: 32590726

Group type: EXPERIMENTAL
Intervention: No-reflow group (331 patients, 29.5% incidence) in the development cohort
Number of subjects: 1658

Group type: EXPERIMENTAL
Intervention: No-reflow risk scoring system tested in validation cohort (536 patients, 30.1% incidence)
Number of subjects: 1658
Study: 34379314

Group type: EXPERIMENTAL
Intervention: Tadalafil 40 mg once daily in pediatric patients with body weight ≥ 40 kg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg once daily in pediatric patients with body weight < 40 kg and aged ≥ 2 years
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Tadalafil doses studied in pediatric population
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Modeling and simulation
Number of subjects: 19

Group type: COMPARATOR
Intervention: Bosentan
Number of subjects: 19
Study: 35972243

Group type: EXPERIMENTAL
Intervention: ICU eDischarge tool
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (preimplementation period)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (nonpreventable adverse events)
Number of subjects: 0
Study: 33947668

Group type: EXPERIMENTAL
Intervention: Pharmacist-coordinated interdisciplinary smoking cessation intervention
Number of subjects: 690

Group type: COMPARATOR
Intervention: Usual care plus Quitline referral
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: Home medicines review (HMR) and home-based pulmonary rehabilitation (HomeBase) for COPD patients
Number of subjects: 690
Study: 35660535

Group type: EXPERIMENTAL
Intervention: Cross‐legged sitting
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sitting on a chair
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Side‐sitting
Number of subjects: 30
Study: 34900780

Group type: EXPERIMENTAL
Intervention: Probiotic 'Visbiome®' (n=8)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (n=7)
Number of subjects: 15
Study: 33499659

Group type: EXPERIMENTAL
Intervention: TF-CBT with adjunctive AAT (TF-CBT+AAT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard TF-CBT
Number of subjects: 0
Study: 33985503

Group type: EXPERIMENTAL
Intervention: Self-managed continuous monitoring
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control group (supervisory visit)
Number of subjects: 198
Study: 35314880

Group type: EXPERIMENTAL
Intervention: DCB
Number of subjects: 132

Group type: COMPARATOR
Intervention: POBA
Number of subjects: 132
Study: 32367666

Group type: EXPERIMENTAL
Intervention: Percutaneous nerve evaluation (PNE) without fluoroscopy
Number of subjects: 74

Group type: COMPARATOR
Intervention: Percutaneous nerve evaluation (PNE) with fluoroscopy
Number of subjects: 74
Study: 35455677

Group type: EXPERIMENTAL
Intervention: Deep NMB
Number of subjects: 144

Group type: COMPARATOR
Intervention: Moderate NMB
Number of subjects: 144
Study: 34038852

Group type: EXPERIMENTAL
Intervention: Pulsed Lavage (PL) used during operation
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control group (no PL)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Pulsed Lavage (PL)
Number of subjects: 176
Study: 33478749

Group type: EXPERIMENTAL
Intervention: Rapid induction (RI) with TCI of propofol effect‐site (CeCALC) 5.4μg/mL (modified Marsh model)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Slow induction (SI) with propofol infusion of 10mg/kg/hour
Number of subjects: 16
Study: 33206752

Group type: EXPERIMENTAL
Intervention: Colonoscopy after 3 hours of colon preparation with 10% mannitol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Colonoscopy after 6 hours of colon preparation with 10% mannitol
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Colonoscopy after 3 hours of colon preparation with 10% mannitol in patients with diabetes mellitus
Number of subjects: 100
Study: 36208619

Group type: EXPERIMENTAL
Intervention: Multicomponent neuromuscular warm-up program
Number of subjects: 112

Group type: COMPARATOR
Intervention: Typical warm-up program
Number of subjects: 112
Study: 33870722

Group type: EXPERIMENTAL
Intervention: Resistance exercise training (RT) for 14 weeks, 3 days/week, alternating high-low-high intensity
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Baseline gene expression
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Response networks identified through WGCNA
Number of subjects: 31
Study: 32271970

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg BID
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg BID
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg subcutaneous injection every 2 weeks (only in OPAL Broaden)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32356365

Group type: EXPERIMENTAL
Intervention: Super high-flux hemodialysis (SHF-HD)
Number of subjects: 15

Group type: COMPARATOR
Intervention: High-volume postdilution online hemodiafiltration (ol-HDF)
Number of subjects: 15
Study: 34600314

Group type: EXPERIMENTAL
Intervention: Original RICWS design
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Alternative RICWS Designs (except for Alternative RICWS Design 1)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control intersections
Number of subjects: 120
Study: 34261874

Group type: EXPERIMENTAL
Intervention: HeartMate Percutaneous Heart Pump (PHP)
Number of subjects: 75
Study: 35274691

Group type: EXPERIMENTAL
Intervention: Anifrolumab (300 mg every 4 weeks for 48 weeks)
Number of subjects: 726

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 726
Study: 33230938

Group type: EXPERIMENTAL
Intervention: Complex functional training intervention initiated by physiotherapist and performed by nurses/nurse assistants (NAs) as part of daily routine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 32764887

Group type: EXPERIMENTAL
Intervention: BD-TAP block with 3 mg/kg of ropivacaine diluted to 60 mL
Number of subjects: 50

Group type: COMPARATOR
Intervention: General anesthesia (Control)
Number of subjects: 50
Study: 33397654

Group type: EXPERIMENTAL
Intervention: Macular Buckling (MB)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Pars Plana Vitrectomy (PPV)
Number of subjects: 53
Study: 32415468

Group type: EXPERIMENTAL
Intervention: Imatinib (single-dose administration)
Number of subjects: 26

Group type: COMPARATOR
Intervention: CYP2B6 516GT carriers
Number of subjects: 26

Group type: COMPARATOR
Intervention: CYP3A4 (*22/*22, *1/*20 and *1/*22 variants)
Number of subjects: 26
Study: 34568362

Group type: EXPERIMENTAL
Intervention: Esketamine (0.1 mg/kg bolus after anesthesia induction, 0.1 mg/kg/h during operation, 0.015 mg/kg/h in PCIA after surgery)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Esketamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline (Control Group)
Number of subjects: 0
Study: 33380574

Group type: EXPERIMENTAL
Intervention: Caudal epidural injections with 1% lidocaine hydrochloride mixed with triamcinolone
Number of subjects: 47

Group type: COMPARATOR
Intervention: No injections (Control Group)
Number of subjects: 47
Study: 34428536

Group type: EXPERIMENTAL
Intervention: urodynamics ultrasound (uUS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: traditional ultrasound (tUS)
Number of subjects: 10
Study: 33473211

Group type: COMPARATOR
Intervention: Recruiters contacting individuals from immigrant and minority ethnic groups
Number of subjects: 0

Group type: COMPARATOR
Intervention: Women in male-dominated professions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Men in female-dominated professions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Evaluation time by recruiters
Number of subjects: 0
Study: 32231364

Group type: EXPERIMENTAL
Intervention: Integrative Adapt Therapy (IAT)
Number of subjects: 331
Study: 36183751

Group type: EXPERIMENTAL
Intervention: Unfermented dietary β-fructan fibers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fermentation of β-fructans by human gut whole microbiota cultures
Number of subjects: 0
Study: 34675369

Group type: EXPERIMENTAL
Intervention: Increased maternal BMI in mid‐gestation
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Greater maternal BMI
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Excessive GWG
Number of subjects: 57

Group type: COMPARATOR
Intervention: Normal-weight mothers with adequate and excessive GWG
Number of subjects: 57
Study: 32385063

Group type: EXPERIMENTAL
Intervention: Whole milk recommendation
Number of subjects: 534

Group type: COMPARATOR
Intervention: Reduced (1%) fat milk recommendation
Number of subjects: 534
Study: 33932990

Group type: EXPERIMENTAL
Intervention: GLP-1 infusion (Group G)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: GLP-1 + Theophylline infusion (Group GT)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Theophylline infusion (Group T)
Number of subjects: 41
Study: 32730173

Group type: EXPERIMENTAL
Intervention: Low PEEP (1 cmH2O)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: High PEEP (9 cmH2O)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Low PEEP MV + surgical laparotomy (LAP)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: High PEEP MV + pneumothorax (PTX)
Number of subjects: 19
Study: 35546454

Group type: EXPERIMENTAL
Intervention: APR-RARP
Number of subjects: 80

Group type: COMPARATOR
Intervention: RS-RARP
Number of subjects: 80
Study: 33222710

Group type: EXPERIMENTAL
Intervention: Ready-to-use therapeutic food (RUTF) sourced from Compact India
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Locally prepared RUTF
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Augmented home-prepared foods
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Treatment phase without hospitalisation
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Treatment phase without fever
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Treatment phase with ≤ 2 episodes of diarrhoea
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Availability of community-based peer support to mothers for feeding
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Better weight-for-height Z-score (WHZ) at enrolment
Number of subjects: 906
Study: 32488885

Group type: EXPERIMENTAL
Intervention: Trazodone 20 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trazodone 60 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trazodone 140 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trazodone-matched placebo
Number of subjects: 0